Cell Signaling in Cancer: From Mechanisms to Therapy

Since 2016, this conference has brought together investigators focused on basic mechanisms of cancer development, translational research, and early-phase clinical research. This year’s program will focus on genetic and molecular mechanisms underlying tumorigenesis that can be exploited for the development of novel forms of therapy. The sessions will disseminate the most up-to-date knowledge and newest technologies surrounding mechanisms and therapeutic targeting of cancer cell signaling pathways.